ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,480, issued on May 26, was assigned to BeOne Medicines I GmbH (Basel, Switzerland).
"Heterocyclic compounds as sting modulators" was invented by Jing Li (Beijing), Sanjia Xu (Beijing), Zhiwei Wang (Beijing), Guoliang Zhang (Beijing), Ce Wang (Beijing), Jianzhuang Miao (Beijing), Lina Gu (Beijing), Gang Chen (Beijing) and Xiaosong Yu (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are heterocyclic compounds that may be used as STING modulators, the process for synthesis and to the use of such compounds in treatment of various diseases including cancers."
The patent was filed on May 27, 2021, under Application No. 17/925,854....